MICHAEL CASSELLA: Open Payments
NPI 1255941738 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 20 payments from 11 companies in 2025. Trend: 2023 $413 · 2024 $372 · 2025 $806
Food & beverage: $770Education: $36
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $259 |
| Janssen Biotech, Inc. | 3 | $131 |
| UROGEN PHARMA, INC. | 3 | $86 |
| ABBVIE INC. | 3 | $78 |
| Endo USA, Inc. | 2 | $58 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $49 |
| Boston Scientific Corporation | 1 | $47 |
| Blue Earth Diagnostics | 1 | $28 |
| Antares Pharma, Inc. | 1 | $28 |
| Procept Biorobotics Corporation | 1 | $24 |
Products named: INTERSTIM, ERLEADA, ZUSDURI, BOTOX, XIAFLEX, PYLARIFY, ACCOLADE SR, POSLUMA.
Industry payments across NH — which companies pay providers there.
